Cargando…
Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully...
Autores principales: | Bhandari, D., Jhaveri, K. D., Shah, H. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015518/ https://www.ncbi.nlm.nih.gov/pubmed/27795634 http://dx.doi.org/10.4103/0971-4065.175985 |
Ejemplares similares
-
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015) -
Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021) -
Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022) -
Successful treatment of nephrotic syndrome due to pregnancy-related crescentic IgA nephropathy: a case report
por: Shima, Hisato, et al.
Publicado: (2023) -
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)